Jun. 22, 2011, 5:52 AM
Jun. 21, 2011, 7:55 AMAstraZeneca (AZN) is in exclusive final talks to sell its Swedish healthcare and dental unit Astra Tech to Dentsply (XRAY) in a transaction that could value the subsidiary at about $1.8B, sources say. Dentsply has outbid private equity group EQT Partners, medical company Biomet and others.
XRAY vs. ETF Alternatives
DENTSPLY International, Inc. is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. The Company also manufactures and markets other consumable medical device products.
Other News & PR